Cytokinetics, Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KK3A.F | EWTX | SLDB | SRRK | BBIO | BMRN | |
|---|---|---|---|---|---|---|
| Market cap | 7.64B | 4.34B | 663.72M | 5.11B | 13.32B | 10.96B |
| P/E (TTM) | — | — | — | — | — | 153.1 |
| Forward P/E | -16.2 | -22.5 | -3.6 | -16.9 | -303.3 | 8.7 |
| Price/book | -49.4 | 9.6 | 1.7 | 20.1 | -5.3 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +14.73% | +162.58% | +16.12% | +50.03% | +25.89% | +1.21% |
| Today | −2.31% | +0.86% | −3.43% | −2.42% | +0.56% | +2.57% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KK3A.F news ›Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 15, 202... SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Cytokinetics initiated with an Outperform at William Blair
William Blair analyst Alethia Young initiated coverage of Cytokinetics (CYTK) with an Outperform rating. Cytokinetics is a commercial-stage spe... Cytokinetics initiated with an Outperform at William Blair William Blair analyst Alethia…
Cytokinetics announces Health Canada approval of Myqorzo for oHCM treatment
Cytokinetics (CYTK) announced that Health Canada has issued a Notice of Compliance authorizing Myqorzo for the treatment of symptomatic obstruct... Cytokinetics announces Health Canada approval of Myqorzo for oHCM treatment Cytokinetics…
Cytokinetics price target lowered to $81 from $85 at BofA
BofA lowered the firm’s price target on Cytokinetics (CYTK) to $81 from $85 and keeps a Neutral rating on the shares. The firm updated estimates... Cytokinetics price target lowered to $81 from $85 at BofA BofA lowered the firm’s price…
Cytokinetics (CYTK) Gets a Hold from Bank of America Securities
In a report released today, Jason Zemansky from Bank of America Securities reiterated a Hold rating on Cytokinetics, with a price target of $81.00. Zemansky covers the Healthcare sector, focusing on stocks such as Cytokinetics, Kura…
Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
The approval by Health Canada is supported by positive results from the pivotal Phase 3 clinical trial, SEQUOIA-HCM, published in the New England Journal of Medicine, which demonstrated statistically significant and clinically meaningful…
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Roche Holding AG (RHHVF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK), Roche Holding AG (RHHVF) and Arrowhead Pharmaceuticals (ARWR) with bullish sentiments. In a report released yesterday,…
Cytokinetics officer proposes $1.03M share sale
Netflix Reports Q3 2026 Earnings: Revenue Rises 12% to $12.87 Billion, Operating Margin 34.6% INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Peraso Receives Production Order Exceeding $2.0…
Cytokinetics EVP Malik sells 3,500 shares under plan
Netflix Reports Q3 2026 Earnings: Revenue Rises 12% to $12.87 Billion, Operating Margin 34.6% INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Peraso Receives Production Order Exceeding $2.0…
Head-To-Head Comparison: Actinium Pharmaceuticals (NYSE:ATNM) and Cytokinetics (NASDAQ:CYTK)
Posted by Tristan Rich on Oct 19th, 2026 Cytokinetics (NASDAQ:CYTK – Get Free Report) and Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
markets.businessinsider.com6
-
stocktitan.net6
-
defenseworld.net2
-
quiverquant.com2
-
themarketsdaily.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.